When does Bristol-Myers Squibb report earnings?
Bristol-Myers Squibb Company · end-of-day data as of Nov 13, 2026
- P/E vs sector-56.3%
- FCF yield+7.2%
- Trendbullish
- MAs4 of 4
- MA20×50Golden 1d ago
- MACD0.13
- Sector▲ +15.9%
- Earnings in83d
- P/E14.1x
- RSI56
- Support-0.1%
- Resistance+3.4%
- Off 52w high-7.6%
- Volume0.9x
- Bollingerupper half
- News
- P/E vs own-5.0%
- ConsensusHold · 28
- PT$66.53 +4.9%
- 52w range$45–$69
- ATR+2.8%
- Off ATH-22.1%
- Insiders-$678K
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
The stock around its reports
Last close $63.43 · +16.3% over 2y · E earnings · D dividend · S split · A analyst rating change
Quarterly results
Q3 FY2026: Revenue +6.9% year over year, free cash flow 29.4% of revenue, operating margin 21.8%.
| Q3 FY2026 | Sep 30, 2026 | $13.07B | 1.05 | $3.84B | 68.3% | 21.8% | 16.5% |
| Q2 FY2026 | Jun 30, 2026 | $12.97B | 1.62 | $3.09B | 71.3% | 31.0% | 25.6% |
| Q1 FY2026 | Mar 31, 2026 | $11.49B | 1.31 | $757M | 70.2% | 29.3% | 23.3% |
| Q4 FY2025 | Dec 31, 2025 | $12.5B | 0.53 | $1.6B | 67.2% | 22.5% | 8.7% |
| Q3 FY2025 | Sep 30, 2025 | $12.22B | 1.08 | $5.99B | 71.9% | 29.8% | 18.0% |
| Q2 FY2025 | Jun 30, 2025 | $12.27B | 0.64 | $3.56B | 72.5% | 30.8% | 10.7% |
| Q1 FY2025 | Mar 31, 2025 | $11.2B | 1.20 | $1.69B | 72.9% | 31.2% | 21.9% |
| Q4 FY2024 | Dec 31, 2024 | $12.34B | 0.04 | $4.06B | 61.0% | 4.1% | 0.6% |